FIELD: medicine.
SUBSTANCE: claimed invention deals with methods for inducing an immune response to an antigen in a patient for treating human diseases by introduction of an immunogenic composition, where the said patient is selected from a population of patients of interest. In addition, the claimed invention deals with methods for determining whether the subject is or is not sensitive to development of a prophylactic or therapeutic immune response after such treatment.
EFFECT: increased efficiency of determination.
18 cl, 4 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| BIOMARKER FOR PATIENT MONITORING | 2010 |
|
RU2555340C2 |
| BIOMARKER FOR PATIENT'S MONITORING | 2010 |
|
RU2542435C2 |
| BIOMARKER FOR PATIENT SELECTION AND RELATED METHODS | 2010 |
|
RU2552292C2 |
| SOLUBLE ICAM-A AS BIOMARKER FOR PREDICTION OF THERAPEUTIC RESPONSE | 2010 |
|
RU2574984C2 |
| RECOMBINANT VIRAL VACCINE | 2007 |
|
RU2453335C2 |
| METHODS OF EX VIVO EXPANSION OF NATURAL KILLER CELLS AND THEIR USE | 2019 |
|
RU2814083C2 |
| COATED ONCOLYTIC ADENOVIRUS FOR ANTICANCER VACCINES | 2015 |
|
RU2695375C2 |
| CHIMERIC ANTIGEN RECEPTORS WITH MUTATED CD28 COSTIMULATION DOMAINS | 2018 |
|
RU2800922C2 |
| PAPILLOMAVIRUS E2 POLYPEPTIDES USED FOR VACCINATION | 2008 |
|
RU2482189C2 |
| BIOLOGICALLY ACTIVATED DRUGS BASED ON CYTOKINES AND METHODS OF USING THEM | 2019 |
|
RU2819307C2 |
